In:
Obstetric Anesthesia Digest, Ovid Technologies (Wolters Kluwer Health), Vol. 41, No. 4 ( 2021-12), p. 173-173
Kurzfassung:
( Anaesthesia . 2020;75:1614–1619) Seroconversion rates for COVID-19 provides data on the pervasiveness and spread of the infection. One challenge is the rate of asymptomatic seroconversion. This has implications for health care providers on the frontline of obstetric care, who may be at increased risk of COVID-19 transmission to and from patients and staff. To date, there are no studies that have provided a baseline rate of seroconversion in frontline, obstetric care providers. The aim of this study was to assess the prevalence of seroconversion in obstetric providers who were not previously diagnosed with SARS-CoV-2 and examine the associations among their characteristics, symptoms, and seroconversion.
Materialart:
Online-Ressource
ISSN:
0275-665X
DOI:
10.1097/01.aoa.0000796120.96487.f6
Sprache:
Englisch
Verlag:
Ovid Technologies (Wolters Kluwer Health)
Publikationsdatum:
2021
ZDB Id:
2071164-5